Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - Λοιμώξεις του αναπνευστικού συστήματος - Αντιβακτηριακά για συστηματική χρήση, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

ptc therapeutics international limited - eladocagene exuparvovec - Μεταβολισμός αμινοξέων, εγγενή σφάλματα - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.